Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial?

S Vivarelli, L Falzone, CM Grillo, G Scandurra, F Torino… - Cancers, 2020 - mdpi.com
… represents a question mark during this pandemic, as its correlation with COVID-19-… to
cancer patients, but they might even be beneficial in COVID-19-positive cancer patients, by …

Immunotherapy summary for cytokine storm in COVID-19

Y Li, W Zhao, J Liu, Z Chen, Q Lv… - Frontiers in Pharmacology, 2021 - frontiersin.org
Immunotherapy through the application of hormones and monoclonal antibodies can … to
COVID-19. We aim to give some conceptual thought to the prevention and immunotherapy of …

Use of immunotherapy in patients with cancer during the COVID-19 pandemic

FA Schutz, DA Bastos, FSM Monteiro - Oncology, 2020 - search.proquest.com
… The patient denied contact with coronavirus disease 2019 (COVID-19) positive patients
and was practicing all measures of COVID-19 protection. A new PET-CT showed an excellent …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
option for patients with COVID-19 [Citation137]. The idea is that the antibodies injected into
a COVID-19 patient … A phase 1/2/3 study (NCT04426695) of hospitalized COVID-19 patients

The next-generation of combination cancer immunotherapy: Epigenetic immunomodulators transmogrify immune training to enhance immunotherapy

RB Mokhtari, M Sambi, B Qorri, N Baluch, N Ashayeri… - Cancers, 2021 - mdpi.com
… This review provides an overview of the current immunotherapy options available, followed
… of immunotherapies, highlighting the challenges that the current global COVID-19 pandemic …

Systemic immunosuppression in times of COVID19: Do we need to rethink our standards?

S Grabbe, S Beissert, A Enk - JDDG: Journal der Deutschen …, 2020 - Wiley Online Library
… to all immunosuppressants and immunotherapeutic agents, as … A report on Covid-19 disease
in 86 patients with a range of … therapy option should be considered especially in patients

Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?

J Kattan, C Kattan, T Assi - Immunotherapy, 2020 - Taylor & Francis
… the lives of thousands of people within a few months. Cancer patients represent a vulnerable
… of ICI administration in cancer patients during the coronavirus pandemic in order to guide …

Immune-based therapy for COVID-19

A Esmaeilzadeh, D Jafari, S Tahmasebi, R Elahi… - Coronavirus Disease …, 2021 - Springer
immunotherapies of COVID-19 include injection of convalescent plasma from recovered …
as new treatment options for SARS-CoV-2. The cell-based immunotherapies include the …

Oncologic immunomodulatory agents in patients with cancer and COVID-19

J Jee, AJ Stonestrom, S Devlin, T Nguyentran… - Scientific Reports, 2021 - nature.com
… for worse COVID-19 outcomes. Evaluation of the specific risks of immunotherapy use in patients
with COVID … It is also notable that of patients with pre-COVID-19 neutropenia treated with …

Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients

M Gonzalez-Cao, MA Basa, T Puertolas, E Muñoz… - MedRxiv, 2020 - medrxiv.org
… This has led some physicians to take precautions about its use in melanoma, and
recommendations have been made on the use of other therapeutic alternatives during the COVID-19